Assistance reverse takeover Solon Eiendom AS
In December 2016, Solon Eiendom AS and Bionor Pharma AS executed a reverse takeover, after which Bionor Pharma ASA take possession of more than 90% of the shares in Solon Eiendom AS by issuance of consideration shares in Bionor Pharma ASA to the shareholders of Solon Eiendom AS. Following the transfer, Bionor Pharma ASA changed name to Solon Eiendom AS, and new ticker is “SOLON”. Solon Eiendom AS is listed on Oslo Stock Exchange (main list). Ro Sommernes assisted Solon Eiendom AS in the transaction, and our team have consisted of Henrik A. Christensen and Nils Petter Hansson.